Danaher main competitors are KLA, Varian Medical Systems, and Lam Research.
Competitor Summary. See how Danaher compares to its main competitors:
- Cargill has the most employees (166,000).
- Employees at KLA earn more than most of the competitors, with an average yearly salary of $107,730.
- The oldest company is Cargill, founded in 1865.
Danaher vs competitors
|Company||Founding Date||Zippia Score||Headquarters||# of Locations||Revenue||Employees|
|New Brunswick, NJ||26||$93.8B||134,500|
|Palo Alto, CA||8||$3.2B||10,000|
|Santa Clara, CA||6||$1.5B||4,875|
|Santa Rosa, CA||8||$4.9B||14,000|
|San Diego, CA||8||$1.1B||2,800|
Danaher Competitors Jobs
Danaher Jobs openings vs Similar Companies
|Company Name||Jobs Openings||Remote Jobs Openings|
Danaher Remote Jobs
Danaher salaries vs Competitors
Compare Danaher Salaries VS Competitors
Compare Danaher Job Title Salaries VS Competitors
|Company||Highest Salary||Hourly Salary|
Varian Medical Systems
Johnson & Johnson
Danaher demographics vs competitors
Compare Gender At Danaher Vs Competitors
|Johnson & Johnson||58%||42%|
Compare Race At Danaher Vs Competitors
|Company||White||Hispanic or Latino||Black or African American||Asian||Unknown||Diversity Score|
Danaher REVENUE Vs Competitors
- Baxter International
- Boston Scientific
Danaher And Similar Companies CEOs
José E. Almeida is a Brazilian businessman. He has served as the chairman and CEO of Baxter International, Inc. since January 2016. He worked for Tyco Healthcare from 1995 to 2002. He was president of Medical Devices division from October 2006 to June 2011. He served as chairman of the board of directors of Covidien since March 2012 and as the president, chief executive officer and a director since July 2011. He became a director of EMC Corporation on Jan 12, 2015 and resigned on October 30, 2015, due to his election as chairman and CEO of Baxter. In 2015, he worked for The Carlyle Group as an Operating Executive in the Global Healthcare group.
Michael F. Mahoney is a Director on the board of the Boys & Girls Club of Boston. He is the Chairman and CEO of Boston Scientific.
Mr. Mattes has served as our Chief Executive Officer and President as well as a member of the Board since his appointment on April 6, 2020. Prior to joining Coherent and beginning in June 2019, he was a Senior Advisor to McKinsey & Company, a leading global management consulting firm, providing corporate and strategic consulting services to various clients of the firm. From January 2018 to May 2019, he was an independent corporate advisor. From 2013 to December 2017, he was the Chief Executive Officer and a member of the board of directors of Diebold Nixdorf Incorporated, a retail and financial services technology systems company. He also served as its President from 2013 to August 2016. Mr. Mattes was the Senior Vice President, Global Strategic Partnerships at Violin Memory, a computer storage systems company, in 2013. He has also held various senior management positions with Hewlett-Packard Co., a computer technologies company. From 2008 to 2011 he was the Senior Vice President and General Manager of Hewlett Packard’s Enterprise Services for the Americas. From 2006 to 2008 he was Hewlett Packard’s Chief Sales Officer for the Enterprise Business. Mr. Mattes spent the first 20 years of his career (between 1985 and 2005) at Siemens, holding a variety of senior leadership positions. These culminated in his role as chief executive officer of Siemens Communications Inc., USA, in Boca Raton, Florida. He received his Diplom-Kaufmann in business administration from Ludwig Maximilan University.
Ron Nersesian is chairman, president, and chief executive officer of Keysight Technologies. In November 2011, he was named executive vice president and chief operating officer of Agilent Technologies. The following year, in November 2012, he was promoted to president and chief operating officer. When Agilent announced the separation of its electronic measurement business in 2013, Nersesian was appointed Keysight president and CEO and led the launch of the new company. Keysight became a public, independent company in November 2014. Nersesian was appointed chairman of Keysight in 2019. Nersesian began his career in 1982 with Computer Sciences Corporation as a systems engineer for satellite communications systems. In 1984, he joined Hewlett-Packard and served in a range of management roles during his tenure. In 1996, Nersesian joined another industry player as vice president of worldwide marketing. He subsequently assumed other senior management roles through 2002, including senior vice president and general manager of the company's digital storage oscilloscope business. Nersesian joined Agilent Technologies in 2002 as vice president and general manager of the company's Design Validation Division. In 2005, he was named vice president and general manager of the company's Wireless Business Unit and manager of Agilent's Santa Rosa, California site. In 2009 Nersesian was named president of Agilent's Electronic Measurement Group. Nersesian holds a bachelor's degree in electrical engineering from Lehigh University and an MBA from New York University, Stern School of Business. He also serves as an independent director on the Board of Directors of Trimble Inc. and as a member of Georgia Tech's Advisory Board.
Rick Wallace serves as the Chief Executive Officer and President of KLA Corporation as well as a member of the company’s Board of Directors. Wallace began as an applications engineer at KLA Instruments in 1988, and has held various general management positions throughout his tenure with the company. Earlier in his career, Wallace held positions with Ultratech Stepper and Cypress Semiconductor.Wallace currently serves on the board of directors of Proofpoint., a security and compliance company.Wallace earned his Bachelor of Science degree in electrical engineering from the University of Michigan and his Master of Science degree in engineering management from Santa Clara University. Wallace lives in the bay area with his wife and three children.
Timothy M. Archer is our president and chief executive officer. Mr. Archer joined us in June 2012 as our executive vice president, chief operating officer. Prior to joining us, he spent 18 years at Novellus Systems, Inc. in various technology development and business leadership roles, including most recently as chief operating officer from January 2011 to June 2012; executive vice president of Worldwide Sales, Marketing, and Customer Satisfaction from September 2009 to January 2011; and executive vice president of the PECVD and Electrofill Business Units from November 2008 to September 2009. His tenure at Novellus also included assignments as senior director of technology for Novellus Systems Japan from 1999 to 2001 and senior director of technology for the Electrofill Business Unit from April 2001 to April 2002. He started his career in 1989 at Tektronix, where he was responsible for process development for high-speed bipolar ICs. Mr. Archer completed the Program for Management Development at the Harvard Graduate School of Business and earned a B.S. degree in applied physics from the California Institute of Technology.
Chris Barry serves as the chief executive officer and a member of the NuVasive Board of Directors. Prior to this role, Mr. Barry served as senior vice president and president of surgical innovations, the second largest business unit at Medtronic with $5.5 billion in annual revenue, from 2015 to 2018. In this role, Chris provided strategic direction to more than 14,000 employees working in 78 countries, including 10 manufacturing sites and multiple R&D centers. Prior to the acquisition of Covidien by Medtronic, Mr. Barry was president, Advanced Surgical Technologies of Covidien, where he led global strategy, product portfolio and U.S. commercial teams for the $3.2 billion global business unit. Mr. Barry spent more than 15 years in increasing commercial and executive leadership roles at Covidien. Mr. Barry received a bachelor’s degree in environmental science from Texas Tech University.
Joined Varian as an intern in 1999, then full time in 2001, and has held multiple cross-functional roles and executive positions during two-decade tenure with the company. Intimate understanding of healthcare, software solutions, medical devices, technology trends, reimbursement trends and strategies that lead to success in targeted channel segments globally. Marketing strategy, new product launch, portfolio strategy, M&A, P&L, restructuring, government relations, and general management experience. Consistent creation of strategies and execution against operating plans, sales goals and market objectives, including extensive experience of both high growth and slow growth periods (turnaround plans) of Varian Medical Systems journey from $500M to over $3B. Including returning Varian to double digit growth following becoming President of the $3B+ P&L of Oncology systems. Strong leadership skills with a track record of creating an inspiring vision and communicating effectively both internally/externally through developing cultural, servant leadership and focusing on people/teams to drive net promoter scores to all-time highs and enable sustainable long-term success.